ClearSky Medical Diagnostics
ClearSky Medical Diagnostics specializes in developing digital technologies for the diagnosis and monitoring of neurodegenerative conditions such as Parkinson's and Alzheimer's. The company leverages expertise in AI & Machine Learning, clinical neurology, and pharmaceutical/MedTech industries to create innovative solutions. Their core offerings include AI/ML services for clinical research and product development, and a portfolio of clinically validated, non-invasive devices for objective symptom assessment. ClearSky's business model is based on providing these AI/ML services and ready-to-deploy intelligent devices. Founded by Professor Stephen Smith, the company has a track record of developing devices for Parkinson's and Huntington's, and is actively researching dementia diagnosis. They emphasize their interdisciplinary team, proven track record in supporting global studies, and leadership in white-box machine learning.
ClearSky Medical Diagnostics
ClearSky Medical Diagnostics specializes in developing digital technologies for the diagnosis and monitoring of neurodegenerative conditions such as Parkinson's and Alzheimer's. The company leverages expertise in AI & Machine Learning, clinical neurology, and pharmaceutical/MedTech industries to create innovative solutions. Their core offerings include AI/ML services for clinical research and product development, and a portfolio of clinically validated, non-invasive devices for objective symptom assessment. ClearSky's business model is based on providing these AI/ML services and ready-to-deploy intelligent devices. Founded by Professor Stephen Smith, the company has a track record of developing devices for Parkinson's and Huntington's, and is actively researching dementia diagnosis. They emphasize their interdisciplinary team, proven track record in supporting global studies, and leadership in white-box machine learning.